Lupus & antiphospholipid syndrome

1. Rheumatology (Oxford)10 Jul 2026

   Methylation and polygenic risk scores capture different features of Systemic Lupus Erythematosus

   Cross-sectional study

2. Lupus Sci Med9 Jul 2026

   Real-world experience with personalised belimumab spacing in sustained SLE remission: a multicentre study

   Cohort study

3. Lupus8 Jul 2026

   Association of galectin-3 in systemic lupus erythematosus: A systematic review and meta-analysis

   Meta-analysis

4. Lupus8 Jul 2026

   Diagnosis to dialogue: Reproductive health conversations and guideline adherence in women with lupus

   Cross-sectional study

5. Lupus8 Jul 2026

   Anifrolumab induces a fast improvement in ultrasound-detected synovitis in systemic lupus erythematosus: Results from a 6-months follow-up ultrasound study

   Cohort study

6. Lupus8 Jul 2026

   Hydroxychloroquine-induced retinopathy in Puerto Ricans with systemic lupus erythematosus: Associated factors and early-onset risk

   Cohort study

7. Rheumatology (Oxford)8 Jul 2026

   Impact of systemic autoimmune diseases in maternal, fetal and neonatal outcomes in Spain

   Cohort study

8. Lupus Sci Med7 Jul 2026

   Upadacitinib enhances platelet procoagulant responses in a subset of healthy individuals and patients with SLE: a pilot study

   Mechanistic study

9. Lupus Sci Med7 Jul 2026

   Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms

   Research article

10. Lupus4 Jul 2026

    Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016–2017

    Cohort study

11. Ann Rheum Dis3 Jul 2026

    A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus

    Diagnostic or prognostic study

12. RMD Open3 Jul 2026

    Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials

    Meta-analysis

13. Lupus Sci Med2 Jul 2026

    Development and validation of a lectin-based assay for detection of IgG Fc glycosylation as a biomarker in lupus nephritis

    Diagnostic or prognostic study

14. Lupus2 Jul 2026

    T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus

    Cross-sectional study

15. Lupus2 Jul 2026

    Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis

    Cross-sectional study

16. Lupus2 Jul 2026

    Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus

    Case-control study

17. Lupus Sci Med1 Jul 2026

    Anti-endothelin receptor A autoantibodies associate with immunovascular risk and activate endothelial signalling in SLE

    Cross-sectional study

18. Lupus Sci Med1 Jul 2026

    Quantitative mapping of prefrontal oxygenation dysfunction and neuropsychiatric symptoms in patients with systemic lupus erythematosus: a multichannel functional near-infrared spectroscopy study

    Cross-sectional study

19. Lupus Sci Med30 Jun 2026

    Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort

    Cohort study

20. Lupus Sci Med29 Jun 2026

    Increasing the utilisation of hydroxychloroquine blood level testing in lupus: a quality improvement project

    Research article

21. Lupus Sci Med29 Jun 2026

    Effects of exercise interventions on core health outcomes in patients with SLE: systematic review and meta-analysis

    Meta-analysis

22. Lupus Sci Med29 Jun 2026

    Old marker, new face: anti-RNP as a sentinel of coronary and peripheral endothelial dysfunction in systemic lupus erythematosus

    Cross-sectional study

23. Lupus28 Jun 2026

    Association of serum and urinary galectin-3 with renal fibrosis in patients with lupus nephritis: A cross-sectional controlled study

    Cross-sectional study

24. RMD Open28 Jun 2026

    Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity

    Cohort study

25. Lupus Sci Med28 Jun 2026

    Type I interferons enhance B cell activation and promote differentiation of double negative 2 cells in SLE

    Mechanistic study

26. Lupus Sci Med25 Jun 2026

    Development of a LASSO-based machine learning model for relapse prediction in lupus nephritis

    Cohort study

27. Lupus Sci Med25 Jun 2026

    Influence of sex and systemic lupus erythematosus disease status on cerebral cortex structure

    Cross-sectional study

28. Lupus25 Jun 2026

    Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort study

    Cohort study

29. Lupus Sci Med24 Jun 2026

    Prognostic value of baseline clinical features in SLE: a cluster analysis

    Cohort study

30. Rheumatology (Oxford)24 Jun 2026

    The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus

    Guideline or statement

31. Lupus23 Jun 2026

    Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis

    Cohort study

32. Lupus23 Jun 2026

    Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndrome

    Cohort study

33. Lupus23 Jun 2026

    Serum RIPK3/MLKL as exploratory biomarker candidates for systemic lupus erythematosus

    Case-control study

34. RMD Open22 Jun 2026

    Incidence and disease burden of bronchiectasis in systemic lupus erythematosus: a nationwide population-based study in Korea

    Cohort study

35. Semin Arthritis Rheum20 Jun 2026

    Soluble urokinase plasminogen activator receptor (suPAR) is associated with intrarenal chronicity features on diagnostic and repeat kidney biopsies in lupus nephritis

    Cohort study

36. Lupus Sci Med18 Jun 2026

    Belimumab as a possible treatment for SLE-associated pulmonary arterial hypertension: the experience from a single centre

    Cohort study

37. Lupus17 Jun 2026

    The lived experiences of woman navigating university with lupus and their primary support persons

    Research article

38. Lupus Sci Med17 Jun 2026

    Phase Ib, multicentre, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab in participants with systemic lupus erythematosus

    Research article

39. Lupus Sci Med17 Jun 2026

    Belimumab induces early and sustained resolution of lupus thrombocytopenia

    Meta-analysis

40. Lupus16 Jun 2026

    Treatment strategies and clinical outcomes in shrinking lung syndrome in systemic lupus erythematosus: An updated systematic review

    Meta-analysis

All 1,848 Briefs in ExploreShowing Briefs 161–200 of 1,848, newest first